Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Haydn, Beaton"'
Autor:
Karin Kaspersson, Ian Gurrell, Elisabeth Bäck, Samantha Budd Haeberlein, Karin Kolmodin, Roland Bürli, Michael J. McKenzie, Susanna Eketjäll, Philip Thorne, Patrik Johansson, Jörg Holenz, Gvido Cebers, Clay W Scott, Mark E. Duggan, Paul R. J. Davey, Haydn Beaton
Publikováno v:
Journal of medicinal chemistry. 61(8)
BACE1 is responsible for the first step in APP proteolysis, leading to toxic Aβ production, and has been indicated to play a key role in the pathogenesis of Alzheimer's disease. The related isoform BACE2 is thought to be involved in processing of th
Autor:
Aaron Rigby, Peter J. H. Webborn, Rob Riley, John Collington, Mark Furber, Brian Springthorpe, Matt Soars, Ash Bahl, Cathy MacDonald, Keith Bowers, Elizabeth Kinchin, Lilian Alcaraz, Rebecca Denton, Haydn Beaton, David Donald, Christopher A. Luckhurst
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 22:7707-7710
The second part of this communication focuses on the resolution of issues surrounding the series of hydroxyamide phenoxypiperidine CCR3/H(1) dual antagonists described in Part I. This involved further structural exploration directed at reducing metab
Autor:
David Cox, Alan V. Wallace, Anthony Ronald Cook, Anders Åberg, and Alan C. Tinker, John A. Tainer, David Cheshire, Haydn Beaton, Phil Mallinder, Ian Millichip, David J. Nicholls, Stephen A. St-Gallay, Sally L. Cooper, Robin J. Rosenfeld, Stephen Connolly, Andrew S. Arvai, Peter Hamley
Publikováno v:
Journal of Medicinal Chemistry. 47:3320-3323
4-Methylaminopyridine (4-MAP) (5) is a potent but nonselective nitric oxide synthase (NOS) inhibitor. While simple N-methylation in this series results in poor activity, more elaborate N-substitution such as with 4-piperidine carbamate or amide resul
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 11:1023-1026
3-Phenyl-3.4-dihydro-1-isoquinolinamine is a weak inhibitor of iNOS and nNOS. Structural variation of 5a results in inhibitors with a range of potency and selectivity for the NOS enzymes, including a potent and very selective iNOS inhibitor 5j.
Publikováno v:
Tetrahedron Letters. 39:1227-1230
A variety of 1-amino-3,4-dihydroisoquinolines substituted at the 3-position and related thienopyridines were prepared by lithiation of ortho-methyl aromatic nitriles, addition to N-trimethylsilylimines and spontaneous cyclisation.
Autor:
Mark, Furber, Lilian, Alcaraz, Christopher, Luckhurst, Ash, Bahl, Haydn, Beaton, Keith, Bowers, John, Collington, Rebecca, Denton, David, Donald, Elizabeth, Kinchin, Cathy, MacDonald, Aaron, Rigby, Rob, Riley, Matt, Soars, Brian, Springthorpe, Peter, Webborn
Publikováno v:
Bioorganicmedicinal chemistry letters. 22(24)
The second part of this communication focuses on the resolution of issues surrounding the series of hydroxyamide phenoxypiperidine CCR3/H(1) dual antagonists described in Part I. This involved further structural exploration directed at reducing metab
Autor:
Mark, Furber, Lilian, Alcaraz, Christopher, Luckhurst, Ash, Bahl, Haydn, Beaton, Keith, Bowers, John, Collington, Rebecca, Denton, David, Donald, Elizabeth, Kinchin, Cathy, MacDonald, Aaron, Rigby, Rob, Riley, Matt, Soars, Brian, Springthorpe, Peter, Webborn
Publikováno v:
Bioorganicmedicinal chemistry letters. 22(24)
The discovery of potent small molecule dual antagonists of the human CCR3 and H(1) receptors is described for the treatment of allergic diseases, for example, asthma and allergic rhinitis. Optimizing in vitro potency and metabolic stability, starting
Autor:
Stephen Connolly, Nigel Gensmantel, Peter Hamley, Richard P. Harrison, Paul Hartopp, Nigel Boughton-Smith, Timothy Nicholas Birkinshaw, Antonio Mete, Haydn Beaton, Sally L. Cooper, Austen Pimm, David Cheshire, Gunilla Andersson, Alan V. Wallace, Anders Åberg, Paul D. Leeson, John Dixon, David Cox, Timothy Jon Luker, Helena Käck, Ian Millichip, Steve St-Gallay, David J. Nicholls, Anne Cooper, Glen Andrews, Tony R. Cook
Publikováno v:
Bioorganicmedicinal chemistry letters. 21(8)
By careful analysis of experimental X-ray ligand crystallographic protein data across several inhibitor series we have discovered a novel, potent and selective series of iNOS inhibitors exemplified by compound 8.
Publikováno v:
ChemInform. 32
3-Phenyl-3,4-dihydro-1-isoquinolinamine is a weak inhibitor of iNOS and nNOS. Structural variation of 5a results in inhibitors with a range of potency and selectivity for the NOS enzymes, including a potent and very selective iNOS inhibitor 5j.
Autor:
Anant M. Ghelani, Alan V. Wallace, Nigel Boughton-Smith, Peter Hamley, Tinker Alan, Haydn Beaton, David J. Nicholls
Publikováno v:
ChemInform. 32
5-Substituted 7-amino-4,5-tetrahydrothieno[2,3-c]pyridines and 6-substituted 4-amino-6,7-dihydrothieno[3,2-c]pyridines were shown to be exceptionally potent inhibitors of inducible and neuronal nitric oxide synthase. Selectivity and potency could be